Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 300.00 |
P174144
Closed
Stefka Slavova , Ali Abukumail
Small and Medium Enterprises Development Organization of Turkey/Küçük ve Orta Ölçekli ??let
October 16, 2020
(as of board presentation)
December 18, 2020
April 23, 2021
US$ 300.00 million
Small and Medium Enterprises Development Organization of Turkey/Küçük ve Orta Ölçekli ??let
2021
US$ 300.00 million
N/A
Moderate
June 30, 2023
Yes
BANK APPROVED
January 1, 2024
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 300.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 300.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 300.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 300.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Dec 1, 2021 | IBRD-91950 | Int Charges | 335,897.10 |
Dec 1, 2021 | IBRD-91950 | Int Charges | 152,479.30 |
Apr 7, 2022 | IBRD-91950 | Loan Disb | 60,000,000.00 |
Mar 10, 2022 | IBRD-91950 | Loan Disb | 60,000,000.00 |
Jun 1, 2022 | IBRD-91950 | Int Charges | 4,019.05 |
Jun 1, 2022 | IBRD-91950 | Int Charges | 203,695.70 |
Jun 1, 2022 | IBRD-91950 | Int Charges | 585,095.75 |
Jun 1, 2024 | IBRD-91950 | Int Charges | 35.47 |
Jun 1, 2024 | IBRD-91950 | Int Charges | 1.41 |
May 14, 2021 | IBRD-91950 | Loan Disb | 1,000,000.00 |
Apr 23, 2021 | IBRD-91950 | Fee Charges | 750,000.00 |
Apr 23, 2021 | IBRD-91950 | Loan Disb | 750,000.00 |
Jun 9, 2021 | IBRD-91950 | Loan Disb | 14,021,575.00 |
Jul 20, 2021 | IBRD-91950 | Loan Disb | 10,000,000.00 |
May 2, 2022 | IBRD-91950 | Loan Disb | 50,000,000.00 |
Oct 22, 2021 | IBRD-91950 | Loan Disb | 5,000,000.00 |
Aug 20, 2021 | IBRD-91950 | Loan Disb | 15,000,000.00 |
Sep 2, 2022 | IBRD-91950 | Loan Disb | 3,325,578.00 |
Dec 1, 2021 | IBRD-91950 | Int Charges | 1,312.50 |
Dec 1, 2021 | IBRD-91950 | Int Charges | 51,118.15 |
Jul 18, 2022 | IBRD-91950 | Loan Disb | 20,000,000.00 |
Jun 1, 2022 | IBRD-91950 | Int Charges | 1,369.85 |
Jun 1, 2024 | IBRD-91950 | Int Charges | 10,010,140.00 |
Jun 1, 2024 | IBRD-91950 | Int Charges | -182.77 |
Jun 1, 2024 | IBRD-91950 | Int Charges | 182.77 |
Dec 18, 2020 | IBRD-91950 | Loan Commitment | 300,000,000.00 |
Oct 30, 2023 | IBRD-91950 | Loan Cancel | 833,911.30 |
Oct 4, 2023 | IBRD-91950 | Loan Disb | -3,564.70 |
Jun 1, 2023 | IBRD-91950 | Int Charges | 1,083.76 |
Jun 1, 2023 | IBRD-91950 | Int Charges | 9,088,751.00 |
Dec 1, 2023 | IBRD-91950 | Int Charges | 1,040.79 |
Dec 1, 2023 | IBRD-91950 | Int Charges | 9,763,365.00 |
Dec 1, 2022 | IBRD-91950 | Int Charges | 32,876.72 |
Dec 1, 2022 | IBRD-91950 | Int Charges | 107,123.28 |
Dec 1, 2022 | IBRD-91950 | Int Charges | 9,688.36 |
Dec 1, 2022 | IBRD-91950 | Int Charges | 4,263,983.00 |
Mar 9, 2023 | IBRD-91950 | Loan Disb | 72,500.00 |
Jan 19, 2022 | IBRD-91950 | Loan Disb | 30,000,000.00 |
Mar 1, 2022 | IBRD-91950 | Loan Disb | 30,000,000.00 |
Name | Review | Date |
---|---|---|
Project Management | Satisfactory | 2022-11-24 |
Procurement | Satisfactory | 2022-11-24 |
Overall Implementation Progress (IP) | Satisfactory | 2022-11-24 |
Progress towards achievement of PDO | Satisfactory | 2022-11-24 |
Financial Management | Satisfactory | 2022-11-24 |
Monitoring and Evaluation | Satisfactory | 2022-11-24 |
INDICATOR | IMPLEMENTATION COMPLETION & RESULTS REPORT: 12-21-2023 |
---|---|
Outcomes | Highly Satisfactory |
Risk to Development Outcome | |
Bank Performance | Highly Satisfactory |
Borrower Performance | |
Government Performance | |
Implementing Agency |
INDICATOR | ICR REVIEW: 06-03-2024 | PROJECT PERFORMANCE ASSESSMENT REPORT: |
---|---|---|
Outcome Rating | Highly Satisfactory | N/a |
Risk To Development Outcome | N/a | |
Bank Performance | Satisfactory | N/a |
Borrower Performance | N/a | |
Government Performance | N/a | |
Implementing Agency | N/a | |
Icr Quality | Substantial | N/a |
M&e Quality | Substantial | N/a |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Share of beneficiary MSEs that survive the COVID-19 crisis for at least six months after receiving performance-based reimbursable support financing | Value | 0.00 | 97.63 | 25.00 |
Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
Comment |
Share of beneficiary surviving MSEs that increase employment relative to the average employment level of the MSE for the 12-month period preceding on which the app [see description for full name] | Value | 0.00 | 83.17 | 25.00 |
Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
Comment |
Share of beneficiary innovative young firms that survive the COVID-19 crisis for at least six months after receiving performance-based reimbursable support financing | Value | 0.00 | 96.97 | 20.00 |
Date | July 27, 2020 | October 5, 2022 | May 31, 2022 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Of applicants that are female-led or -owned young innovative MSEs or with female majority workforce, share that meet the eligibility criteria and receive reimbursable support financing | Value | 0.00 | 78.00 | 20.00 |
Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
Comment |
KOSGEB Firm Engagement: Beneficiary young firms reporting that the provided reimbursable support financing reflected their needs | Value | 0.00 | 86.00 | 30.00 |
Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
Comment |
Of applicants that are female-led or -owned MSEs or with female majority workforce, share that meet the eligibility criteria and receive reimbursable support financing | Value | 0.00 | 62.00 | 20.00 |
Date | July 27, 2020 | June 30, 2022 | May 31, 2022 | |
Comment |
KOSGEB Firm Engagement: Beneficiary firms reporting that the provided reimbursable support financing reflected their needs | Value | 0.00 | 90.00 | 30.00 |
Date | July 27, 2020 | June 30, 2022 | January 31, 2022 | |
Comment |